AMGEN Inc (NASDAQ: AMGN)’s stock price has soared by 2.21 in relation to previous closing price of 303.01. Nevertheless, the company has seen a gain of 6.37% in its stock price over the last five trading days. reuters.com reported 2025-02-24 that U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert A. Bradway said at the inauguration of the site.
Is It Worth Investing in AMGEN Inc (NASDAQ: AMGN) Right Now?
AMGEN Inc (NASDAQ: AMGN) has a higher price-to-earnings ratio of 41.04x compared to its average ratio. AMGN has 36-month beta value of 0.53. Analysts have mixed views on the stock, with 10 analysts rating it as a “buy,” 5 as “overweight,” 15 as “hold,” and 2 as “sell.”
The public float for AMGN is 536.11M, and currently, short sellers hold a 2.38% ratio of that float. The average trading volume of AMGN on February 25, 2025 was 3.71M shares.
AMGN’s Market Performance
AMGN’s stock has seen a 6.37% increase for the week, with a 11.46% rise in the past month and a 10.63% gain in the past quarter. The volatility ratio for the week is 2.03%, and the volatility levels for the past 30 days are at 2.24% for AMGEN Inc. The simple moving average for the past 20 days is 5.64% for AMGN’s stock, with a 1.22% simple moving average for the past 200 days.
Analysts’ Opinion of AMGN
Many brokerage firms have already submitted their reports for AMGN stocks, with BofA Securities repeating the rating for AMGN by listing it as a “Underperform.” The predicted price for AMGN in the upcoming period, according to BofA Securities is $256 based on the research report published on December 10, 2024 of the previous year 2024.
Citigroup gave a rating of “Neutral” to AMGN, setting the target price at $335 in the report published on November 14th of the previous year.
AMGN Trading at 11.69% from the 50-Day Moving Average
After a stumble in the market that brought AMGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.70% of loss for the given period.
Volatility was left at 2.24%, however, over the last 30 days, the volatility rate increased by 2.03%, as shares surge +12.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.56% upper at present.
During the last 5 trading sessions, AMGN rose by +6.37%, which changed the moving average for the period of 200-days by +3.42% in comparison to the 20-day moving average, which settled at $293.19. In addition, AMGEN Inc saw 18.83% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AMGN starting from Santos Esteban, who sale 8,711 shares at the price of $292.84 back on Feb 19 ’25. After this action, Santos Esteban now owns 71,546 shares of AMGEN Inc, valued at $2,550,903 using the latest closing price.
REESE DAVID M, the EVP & Chief Technology Officer of AMGEN Inc, sale 25,225 shares at $304.44 during a trade that took place back on Feb 21 ’25, which means that REESE DAVID M is holding 36,922 shares at $7,679,524 based on the most recent closing price.
Stock Fundamentals for AMGN
Current profitability levels for the company are sitting at:
- 0.21 for the present operating margin
- 0.61 for the gross margin
The net margin for AMGEN Inc stands at 0.12. The total capital return value is set at 0.1. Equity return is now at value 67.55, with 4.33 for asset returns.
Based on AMGEN Inc (AMGN), the company’s capital structure generated 0.91 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 10.23. The interest coverage ratio of the stock is 2.27.
Currently, EBITDA for the company is 15.69 billion with net debt to EBITDA at 3.61. When we switch over and look at the enterprise to sales, we see a ratio of 6.44. The receivables turnover for the company is 4.91for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.26.
Conclusion
To put it simply, AMGEN Inc (AMGN) has had a better performance in recent times. Analysts have a bearish opinion on the stock, with some rating it as a “sell” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
